Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Bair Hugger Settlement Mediator Appointed After Infection Lawsuits Returned to MDL For Trial The Court must now decide whether to remand the cases to their originating courts for trial, or to hold additional bellwether trials in hopes of sparking a settlement agreement or other resolution. February 4, 2022 Irvin Jackson Add Your Comments The U.S. District Judge presiding over thousands of recently reinstated Bair Hugger lawsuits has appointed a mediator to explore potential settlements or resolution of outstanding issues in the cases, before deciding whether large numbers of claims will be remanded back to federal courts nationwide for individual trial dates. 3M Company faces more than 5,000 product liability lawsuits over surgical infections allegedly caused by the Bair Hugger forced-air warming blanket, which has been commonly used during hip and knee replacements. However, plaintiffs allege that the design disrupts the airflow in the operating room, causing bacteria and debris from the floor to enter the sterile surgical area, resulting in devastating infections and the need for multiple surgical procedures to remove and replace the infected joint. In 2019, following several years of litigation, the federal Bair Hugger litigation was dismissed, after the judge ruled that plaintiffs’ expert witnesses were precluded from testifying at trial. However, the U.S. Court of Appeals for the Eighth Circuit overturned that decision in August 2021, returning each of the individual Bair Hugger infection lawsuits back to the trial court for further proceedings. The cases are now pending before U.S. District Judge Joan Ericksen, who has presided over coordinated discovery and pretrial proceedings, and now must decide whether each of the lawsuits should be remanded back to the U.S. District Courts where the claim originated for trial, or whether additional “bellwether” trials should be scheduled in the federal MDL to help the parties gauge how juries may respond to certain evidence and testimony that may be repeated throughout the claims. Learn More About Knee and Hip Surgery Infection Lawsuits Bair Hugger warming blankets may be the cause of knee or hip surgery infections. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Knee and Hip Surgery Infection Lawsuits Bair Hugger warming blankets may be the cause of knee or hip surgery infections. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In a joint status report (PDF) issued on January 22, the parties took divergent positions on how the litigation should proceed. While the plaintiffs have urged the court to work with the parties to design a plan for the remand of several large “waves” of cases back to courts nationwide, for simultaneous case-specific discovery and trial, 3M indicates that would be premature. The manufacturer indicates that additional bellwether trials are warranted, indicating that another round of cases can be “trial-ready” by early 2023, allowing the parties to learn additional information that was not discovered during prior rounds of bellwether trials. In response to the filing, Judge Ericksen issued a court order (PDF) on February 2, appointing retired U.S. Magistrate Judge Arthur Boylan as a special mediator in the case. While reinstating the cases and some of plaintiffs’ expert testimony, the appellate court did exclude some parts of their testimony, and refused a plaintiffs’ request to unseal some filings in the appeals process. The impact on where the litigation goes from here remains to be determined. The decision means 3M once again face thousands of hip infection lawsuits and knee infection lawsuits filed in the federal court system. If a settlement agreement cannot be reached, it will be up to the court whether to move forward with bellwether trials in hopes of reaching a resolution for the cases, or to remand them to their originating courts for trials as plaintiffs have requested. Tags: 3M Company, Antibiotics, Arizant Healthcare, Bair Hugger, Forced Air Warming, Hip Infection, Infection, Knee Infection, Warming Blanket More Bair Hugger Lawsuit Stories 3M Seeks Dismissal of More Than 100 Bair Hugger Infection Lawsuits March 11, 2025 Supreme Court Rejects 3M Appeal Over Surgical Warming Blanket Infection Lawsuit May 17, 2022 Supreme Court Review Sought For 3M Bair Hugger Appeal February 10, 2022 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025) Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)